BESPAK EUROPE LIMITED

Values shown as filed in the company's annual accounts. — indicates the figure wasn't present under that line item in that period. About these numbers

• Turnover

  +3.3%

  £188,729,000 → £195,009,000

• Cash

  +141.3%

  £75,000 → £181,000

• Net assets

  -5.2%

  £184,157,000 → £174,648,000

• Employees

  -4.7%

  856 → 816

• Operating profit

  +4.5%

  £43,761,000 → £45,751,000

• Profit before tax

  -11.8%

  £55,620,000 → £49,075,000

• Wages

  -4.1%

  £35,487,000 → £34,019,000

Each % is (latest − prior) ÷ |prior| for the line item as filed. The comparison is only shown when the latest and prior accounts cover broadly equal-length periods — short or long stubs (typical around incorporation or a year-end change) are suppressed rather than misrepresented. Lines a company doesn't report are omitted. About these numbers

Margins divide P&L lines by turnover. Gearing is liabilities over total assets. Current ratio is current assets over creditors falling due within one year. Interest cover is operating profit over absolute finance costs. Sector-distribution context coming next.

1. BESPAK EUROPE LIMITED 1998-04-24 → present
2. FIVESOLE LIMITED 1998-02-24 → 1998-04-24

Accounting basis

FRS 101

Reporting scope

Standalone (parent only)

Auditor

Ernst & Young LLP

Audit opinion

Unqualified (clean)

Going concern

Affirmed

“The financial statements have been prepared on a going concern basis which the directors consider to be appropriate for the following reasons. The company is part of a cash pooling arrangement with its parent, Bespak Limited. A cash flow forecast for the period to 31 August 2026 (being the going concern review period) has been prepared for the Bespak Limited group as cash is managed at this level. The cash flow forecast shows that positive cash is maintained throughout the review period and indicates that, taking account of reasonably possible downsides, the group will have sufficient cash to meet its liabilities as they fall due.”

Significant events

• “On 1 April 2024, Bespak Limited completed a carve-out from Recipharm, uniting the UK's Kings Lynn valve site, Holmes Chapel fill-finish site, and the US R&D laboratory, plus Resyca (Netherlands/Germany) under one CDMO umbrella focusing on inhalation delivery systems.”
• “During the year, a loan receivable of £45,872,000 due from Consort Medial Limited was forgiven via formal deed of release and recognised directly to reserves.”
• “In July 2025, the Company settled its group relief balances with other UK subsidiaries within the RoarHoldco group, totalling £23.6 million at 31 December 2024, for cash consideration of £3.4 million, with the remaining £20.2 million waived.”

Auditor, going-concern and subsidiary information is drawn from the narrative of the latest annual accounts. About these numbers

Filings

5

last 12 months

Capital events

0

last 24 months

Officers appointed

0

last 12 months

Officers resigned

1

last 12 months

Direct counts from the register. No score, no rating — see the Filing timeline for the underlying events.